ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025
Understanding phage Receptor-binding protein interaction with host surface receptor: the key for phage-Mediated detection and elimination of Pseudomonas aeruginosa.
Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Therapeutic Potential of Phages in Multi-Drug Resistance Infections and Future Directions.Viruses · 2026Review
- Phage Therapy Enhanced by Using Engineered Bacteriophages: A Powerful Antibacterial Tool to Address the Dilemma Posed by Multidrug-Resistant Bacterial Infections.International journal of molecular sciences · 2026Review
- Engineering a T7 bacteriophage to attenuate LPS-driven inflammatory responses during bacteriolysis.Applied and environmental microbiology · 2026Article
- The gp38 protein inhibits host adsorption of phage vB_EcoM_SD286.Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Pseudomonas aeruginosa poses a significant clinical challenge due to its intrinsic and acquired antimicrobial resistance and robust biofilm formation, which complicates treatment. Bacteriophages (phages), viruses targeting bacteria, are emerging as a promising alternative or adjunct to combat multidrug-resistant P. aeruginosa infections. This review systematically examines the taxonomic diversity of phages infecting P. aeruginosa, with emphasis on those that remain unclassified at the family taxonomic level, such as Pbunavirus and Pakpunavirus. It comprehensively synthesizes current knowledge on phage receptor-binding proteins (RBPs) - the molecular determinants of host specificity - and their corresponding receptors on the P. aeruginosa surface, such as lipopolysaccharide (LPS), pili, flagella, outer membrane proteins, and alginate. Critically, the review underscores the urgent need to decipher the precise molecular mechanisms governing RBP-receptor interactions. A deeper understanding of these specific recognition events is paramount. This knowledge is essential not only for rationally optimizing phage therapy efficacy, including through engineered phages or RBP-based antimicrobials, but also for developing highly sensitive and specific phage-derived diagnostic tools, utilizing whole phages or purified RBPs as recognition elements for rapid P. aeruginosa detection.
Indexed as
Identifiers
40965617What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.